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GLUCURONIDASE AND THE ASSOCIATED PROTEIN EGASYN 
IN MOUSE TISSUES 
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From The Department ofMolecular Biology, Roswell Park Memorial Institute, Buffalo, New York 
14263 
ABSTRACT 
Mouse/3-glucuronidase has a dual intracellular localization, being present in both 
endoplasmic reticulum and lysosomes of several tissues. Previous studies demon- 
strated that the protein egasyn is complexed with microsomal but not lysosomal 
glucuronidase and that a mutant lacking egasyn is deficient in microsomal, but not 
lysosomal, glucuronidase. By means of a recently developed radioimmunoassay 
for egasyn, the relationship between microsomal glucuronidase l vels and egasyn 
levels has been examined in various adult tissues, during postnatal development in
liver, and after androgen induction of glucuronidase in kidney. The results 
indicate that the relative availability of egasyn determines the balance between 
glucuronidase incorporation into membranes and that into lysosomes. 
Mouse glucuronidase is a useful system for studies 
of mechanisms bringing about the intracellular lo- 
calization of enzymes. A body of genetic and bio- 
chemical information concerning the expression of 
glucuronidase is available (for reviews, see 3, 7, 
27), and the enzyme is unusual in that it has a dual 
intracellular location, being present in both lyso- 
somes and the membrane of the endoplasmic re- 
ticulum (microsomes) ofseveral tissues (4, 5, 6, 9, 
19, 26). The intracellular distribution of glucuron- 
idase is tissue specific. All organs contain lysoso- 
mal glucuronidase but only some, including liver, 
kidney, and lung, contain microsomal glucuroni- 
dase (9, 10, 34). The enzyme at both sites is 
similar in thermal stability, antigenicity, and ki- 
netic parameters, and by means of genetic mutants 
it has been shown that the enzyme at both subcel- 
lular sites is derived from the same structural gene, 
Gus, on chromosome 5 (8, 17, 18, 26, 28). 
Evidence both biochemical nd genetic suggests 
that the binding of mouse glucuronidase to endo- 
plasmic reticulum membrane is stabilized by the 
formation of noncovalent complexes with egasyn, 
a membrane-bound glycoprotein. Glucuronidase 
is present in lysosomes as a free tetramer, termed 
L, of molecular weight 280,000 (19, 20, 34, 37). 
The microsomal enzyme is extracted by means of 
the detergent Triton X-100 as a series of higher 
molecular weight aggregates, termed M1, M2, 
M3, and M4 (34). These consist of a glucuroni- 
dase tetramer core, termed X, complexed with, 
respectively, one, two, three or four molecules of 
egasyn, whose molecular weight is 64,000 (21,34, 
36). The two tetrameric forms of glucuronidase, X 
and L, appear to differ by covalent modification. 
At neutral pH, form L is slightly more negative 
than X, and there is a small difference in electro- 
phoretic mobility in the presence of sodium dode- 
cyl sulfate (SDS) (36). 
The assembly of the M form complexes depends 
upon a genetic locus, Eg, on chromosome 8 (9, 
10, 14, 34). A defect at this locus, termed Eg ~ is 
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present in the mouse strain YBR and results in the 
absence of glucuronidase activity in microsomes, 
although Eg o mice contain normal levels of the 
lysosomal enzyme (9, 10, 14, 34). Recently, it has 
been found that the primary defect in Eg o mice is a 
deficiency of egasyn (22). 
We now report evidence that in normal mice it 
is the quantitative availability of egasyn which 
determines the distribution of glucuronidase be- 
tween lysosomes and microsomal membranes.  
The results also suggest that the integration of 
glucuronidase into microsomal membranes i con- 
trolled, among cell types and during development, 
by the production of egasyn. These studies be- 
came possible with the availability of a specific 
radioimmunoassay for egasyn (21). 
MATERIALS AND METHODS 
Animals and Homogenates 
The inbred mouse strains C57BL/6J and A/J were 
obtained from The Jackson Laboratory (Bar Harbor, 
Me.) and the inbred mouse strain YBR/WiCv (YBR) 
was raised in our own colony. At the time of dissection, 
mice were about 2 mo of age. Tissues were homogenized 
in 9 vol of ice-cold 0.02 M imidazole, 0.25 M sucrose, 
pH 7.4, in a Polytron (Brinkman Instruments Inc., 
Westbury, N.Y.) homogenizer, and were stored at 
-20~ For studies involving quantitation of the micro- 
somal (M forms) of glucuronidase, homogenates were 
used fresh or, at most, once frozen, since repeated 
freeze-thawing disrupts partially the M forms (34). 
Glucuronidase Assay 
A fluorimetric assay employing the substrate 4-meth- 
ylumbelliferyl-fl-D-glucuronide (Sigma Chemical Co., St. 
Louis, Mo.) was used. The sample was incubated at 37~ 
with 0.4 mM substrate and 0.1 M sodium acetate, pH 
4.6, in a volume of 0.1 ml. The reaction was terminated 
by the addition of 1 ml of 0.1 M sodium carbonate. 
Fluorescence was determined with an Aminco 4-7439 
fluorimeter (American Instrument Co., Travenol Labs 
Inc., Silver Spring, Md.) equipped with a Coming 7-60 
excitation filter (Coming Glass Works, Science Products 
Div., Coming, N.Y.) and a Kodak 2A emission filter 
(Eastman Kodak Co., Rochester, N.Y.). One unit of 
activity is that amount of enzyme hydrolyzing 1 /zmol of 
substrate per hour. 
Polyacrylamide Gel Electrophoresis 
Electrophoresis was performed essentially as has been 
described previously (34). The detergent Triton X-100 
(Sigma) was added to homogenates to a final concentra- 
tion of 2%, and the mixture was allowed to stand on ice 
for 30 min, when it was centrifuged at 100,000 g for 30 
rain. This method results in the complete solubilization 
of microsomal glucuronidase and preserves the M forms 
intact (34). Homogenate supernatant solutions (10/~1) 
were applied to 7% polyacrylamide gels at pH 8.1, 
prepared according to Clarke (1), and 300 v (constant 
voltage) were applied for 2.5 h. Glucuronidase activity 
was visualized with naphthol-AS-BI-glucuronide as sub- 
strate (11, 12). This method results in the clear separa- 
tion of the M forms and the L form of glucuronidase. 
Gels were scanned at 550 nm with a Coming densitome- 
ter (Coming Medical, Coming Glass Works, Medfield, 
Mass.). Electrophoretic separation of microsomal and 
lysosomal forms, followed by scanning and peak integra- 
tion, was used in estimating the fraction of glucuronidase 
present in microsomes The validity of this method has 
previously been demonstrated by showing that the M 
forms of mouse organs, including androgen-induced ki - 
ney, are exclusively microsomal nd that 90-95% of the 
L form is lysosomal (34, 36). 
Isolation of Egasyn and Preparation 
of Antibody 
These procedures were carried out as described previ- 
ously (21). Briefly, microsomal glucuronidase-egasyn 
complexes were released from the particulate fraction of 
mouse liver and kidney, and were precipitated by the 
addition of anti-mouse fl-glucuronidase antibody, pre- 
pared in goats (36, 37). Egasyn was then selectively 
released from these immunoprecipitates by either treat- 
ment with 0.5% sodium deoxycholate or incubation for 
5 rain at 50~ in 0.02 M Tris, 0.15 M NaC1, pH 7.5 (21). 
The isolated egasyn was homogeneous as judged by 
polyacrylamide gel electrophoresis in the presence of 
SDS by the method of Laemmli (15). The yield of egasyn 
from 100 g of pooled livers and kidneys averaged 100 t~g 
to 200/~g for most mouse strains. 
Antiserum to egasyn was prepared in rabbits by using 
intradermal injections at multiple sites of a total of about 
50 /zg of egasyn emulsified in Freund's complete adju- 
vant. Injections were given at intervals of about 2 wk, 
and rabbits were bled at 8 wk. Antiserum to egasyn 
reacted with free egasyn and with the M forms of glucu- 
ronidase but was unreactive towards glucuronidase that 
was not complexed with egasyn (21). Preimmune serum 
was unreactive with egasyn. 
Radioimmunoassay 
This procedure was carried out as previously de- 
scribed (21). Briefly, egasyn was labeled with ~5I 
(Amersham-Searle Corp., Arlington Heights, Ill., car- 
der free) using chloramine-T essentially as described by 
Hunter (13). Samples to be assayed were first extracted 
with Triton X-100 at a final concentration of 2%. This 
procedure solubilized egasyn and egasyn-glucuronidase 
complexes (21). All dilutions for the assay were made in 
0.02 M Tris, 0.15 M NaCI, 0.1% Triton X-100, 0.1% 
bovine serum albumin, pH 7.4. Assays were carried out 
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in 0.6- x 5-cm culture tubes (Kimble Products Div., 
Owens-Illinois, Inc., Toledo, Ohio). The sample was 
mixed with antiegasyn antibody in a volume of 100/zl in 
the presence of 1% sodium deoxycholate and incubated 
for 1 h at 37~ and 24 h at 4~ The antiegasyn antibody 
added represented about a 500-fold dilution of antise- 
rum and was enough to bind about 50% of the labeled 
egasyn, to be added at the next step. The presence of 
sodium deoxycholate was required to unmask antigenic 
sites of egasyn (21 ). Egasyn labeled with 1~I (4,000 cpm, 
in 50 /~1) was then added, and the mixture was further 
incubated for 1 h at 37~ and for 72 h at 4~ The free 
and antibody-bound egasyns were then separated by a 
double antibody precipitation method in which 30 p,1 of 
goat antibody to rabbit IgG and 40 /zl of 4% control 
rabbit serum (as carrier) were added. This mixture 
was incubated for 1 h at 37~ and for 4 h at 4~ when 
the immunoprecipitate was sedimented by centrifugation 
at 10,000 g for 10 min. The pellet was washed and the 
radioactivity in the pellet was determined with a gamma 
counter (Biogamma model, Beckman Instruments, Inc., 
Fullerton, Calif.). A preparation of purified egasyn was 
used as the standard in each experiment. 
RESULTS 
Tissue Distribution 
Previous studies have shown that the intracellular 
distribution of mouse glucuronidase differs among 
tissues (10, 34). Although all organs contain lyso- 
somal glucuronidase activity, only some, including 
liver, kidney, and lung, contain microsomal glueu- 
ronidase. Among tissues, the levels of egasyn 
show a strong correlation with the levels of glueu- 
ronidase in microsomes (Fig. 1 and Table I). 
Liver, the richest source of microsomal glucuroni- 
dase, contained about 56 ~g of egasyn per gram of 
tissue, and kidney, with less microsomal enzyme, 
contained about 10 /zg of egasyn per gram of 
tissue. Brain and spleen lacked both microsomal 
glucuronidase and egasyn, while lung contained 
only trace levels of each (Table I). Thus, the 
production of egasyn in each tissue appears to 
determine the proportion of total glucuronidase 
that is incorporated into microsomal membrane. 
The lack of correlation between the total levels 
of glucuronidase and egasyn among tissues sug- 
gests that the synthesis of each protein is regulated 
independently. We have confirmed this by testing 
the response in kidney of both proteins after an- 
drogen administration. Androgens induce kidney 
glucuronidase 20-50 fold, depending upon the 
mouse strain (35). Egasyn, however, proved to be 
totally nonresponsive to testosterone (Table II). 
In both liver and kidney, no significant differences 
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FIGURE 1 Radioimmunoassay of egasyn. Samples 
were prepared by homogenizing organs in 9 vol of 0.02 
M imidazole, 0.25 M sucrose, pH 7.4, using a Polytron 
homogenizer (Brinkman Instruments). Antibody pre- 
pared against mouse egasyn was incubated first with 
sample and then with egasyn labeled with iodine-125, as 
described in Materials and Methods. The presence of 
egasyn was detected by the displacement of radioactivity 
from the antiegasyn antibody. Unlabeled, purified ega- 
syn was used as the standard. A Distribution of egasyn 
in tissues of a typical C57BL/6J female. Egasyn standard 
(O-O) ,  liver (O-O), kidney ( I - I ) ,  lung ([2-r-1), 
spleen (A - &) and brain (A - A). B Egasyn content of 
livers of strain YBR mice (which carry the defective Eg o 
allele) and strain C57BL/6J mice (which carry the nor- 
mal Eg + allele). Egasyn standard (O- I ) ,  C57BL/6J 
(O-  O), (C57BL/6J x YBR)F1 (A - A), YBR (A - A). 
in egasyn content were observed between male 
and female animals or between testosterone- 
treated and control females. Thus, egasyn and 
glucuronidase are under independent hormonal 
control. 
Development 
Preliminary observations of Swank 1 suggested 
that the fraction of glucuronidase present in mi- 
i R. T. Swank. Personal communication. 
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TABLE I 
Levels of Egasyn and of Micros9 Glucuronidase in Mouse Tissues 
Total glucuronidase Microsomai glucuronidase Egasyn 
Strain Tissue mean --. S.E. mean -+ S.E. mean • S.E. 
U/g tissue uIg tissue #gig tissue 
C57BL/6 liver 32.3 --- 1.9 12.0 - 0.5 56.1 --- 4.1 
C57BL/6 kidney 8.4 --- 0.1 1.9 - 0.1 9.1 - 0.6 
C57BL/6 lung 9.4 - 1.5 1.2 - 0.1 trace 
C57BL/6 spleen 25.5 --- 1.9 not detectable not detectable 
C57BL/6 brain 2.2 - 0.1 not detectable not detectable 
YBR liver 21.1 --- 2.0 not detectable not detectable 
YBR kidney 5.9 - 0.3 not detectable not detectable 
(C57BL/6 x YBR)F1 liver 27.8 _-+ 1.4 10.0 _ 0.6 25 _+ 1.8 
(C57BL/6 x YBR)F1 kidney 6.7 -- 0.3 1.5 -- 0.1 - 
Female mice, about 60 days of age, were used. The fraction of glucuronidase in microsomes was determined by 
electrophoretic separation of lysosomal and micros9 forms, as described in Materials and Methods. 
TABLE II 
Effect of Androgen upon the Levels of Egasyn and 
Glucuronidase in Kidney 
Egasyn Glucuronidase 
strain Control Induced Control Induced 
#gig kidney U/g kidney 
A/J 10.8 10.0 7.0 285 
C57BL/6J 9.1 8.0 5.2 92 
Female mice, about 60 days of age, were used. Testos- 
terone pellets (Schering Corp.) were implanted subcuta- 
neously, and mice were sacrificed about 2 wk after tes- 
tosterone implantation. Control mice received no testos- 
terone treatment. Assays were performed on the pooled 
kidneys of three or more mice. 
crosomal membrane undergoes a large increase 
immediately after birth. As a further test of the 
hypothesis that the availability of egasyn deter- 
mines the extent of membrane binding of glucu- 
ronidase egasyn concentrations and levels of mi- 
crosomal glucuronidase were compared in mouse 
liver during postnatal development. Neither ega- 
syn nor micros9 glucuronidase is present o an 
appreciable xtent in liver at birth (Fig. 2). After 
birth, the levels of both egasyn and microsomal 
glucuronidase increase rapidly and then plateau at 
about 15 days of age (Fig. 2). Thus, the correla- 
tion between the levels of egasyn and microsomal 
glucuronidase applies not only to the different 
tissues but also during the development of a single 
tissue. 
Eg~ + Heterozygotes 
An apparent exception to the correlation be- 
tween levels of egasyn and membrane binding of 
glucuronidase is the observation that, although F~ 
heterozygotes of a cross between ormal mice and 
the Eg o mutant contain only half-normal levels of 
egasyn (22), they nevertheless retain the same 
proportion of microsomal glucuronidase as their 
normal parents (Fig. 1 and Table I). This unex- 
pected result may be related to the presence of an 
excess of egasyn in liver and kidney. We have 
previously estimated that only about 10% of the 
bd 
= o 1 
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I J i I / /  JO 
o K) 2O 30 4O AIXILT 
DAYS OF  AGE a .  
FIGURE 2 Egasyn levels in developing mouse liver. All 
mice were of strain C57BL/6J and were born on day 0. 
Each point represents the pooled organs of 3 or more 
mice. Livers from mice on day 14 of gestation, about 6 
days before birth, contained no detectable gasyn. 
Egasyn (O-e) ,  microsomal glucuronidase (  9  0). 
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TABL~ III 
Effect of Androgen on the Levels of Egasyn Complexed with Glueuronidase in Kidney 
Glucuronidase forms 
Total L M1 M2 M3 M4 
Uninduced kidney 
glucuronidase ( U/g kidney) 5.2 
egasyn complexed with glu- 0.50 
curonidase (p.g/g kidney) 
Induced kidney 
glucuronidase ( U/g kidney) 92.0 
egasyn complexed with glu- 8.1 
curonidase ( lag/g kidney) 
3.8 0.17 0.24 0.47 0.47 
0 0.02 0.06 0.18 0.24 
53.4 20.7 11.3 5.5 1.1 
0 2.6 2.9 2.1 0.5 
Female C57BL/6J mice, about 60 days of age, were used. Mice were treated for 2 wk with testosterone as described 
in Table II. Kidneys were homogenized in 9 vol of 0.02 M imidazole, 0.25 M sucrose, pH 7.4, and the homogenates 
were extracted with 2% Triton X-100. The solutions were centrifuged at 100,000 xg for 60 min, and the supernatant 
solutions were electrophoresed and stained for glucuronidase activity as described inMaterials and Methods. The gels 
were scanned at 550 nm and peak integration gave the glucuronidase activity present in each form. One unit of 
glucuronidase activity corresponds to 0.6/~g of glucuronidase 2 (35). Using this value, and the molecular weights of 
egasyn (64,000) and glucuronidase (75,000 per subunit), and assuming that M1, M2, M3 and M4 contain, 
respectively, 1 2, 3, and 4 molecules of egasyn per glucuronidase t tramer, the amount of egasyn in each 
glucuronidase form was calculated. 
egasyn in C57BL/6J liver is complexed with glucu- 
ronidase (21), and from the distribution of glucu- 
ronidase among its microsomal forms we estimate 
that only a small fraction of egasyn in uninduced 
female kidney is complexed with glucuronidase 
(Table III). 
To test whether this explanation is correct, we 
have taken advantage of the androgen inducibility 
of glucuronidase, but not egasyn (Table II), to 
compare heterozygotes and their normal counter- 
parts under conditions in which egasyn is not in 
excess. Swank and Paigen (34) have previously 
shown that there is a large increase in microsomal 
as well as lysosomal glucuronidase in kidney after 
androgen induction. Following induction of nor- 
mal kidney, virtually all of the egasyn becomes 
complexed with glucuronidase (Table III). This is 
also reflected in a shift in the proportion of the M 
forms of glucuronidase toward the lower molecu- 
lar weight forms containing fewer molecules of 
egasyn (Table III). In strains which have even 
higher inducibility of glucuronidase than the 
C57BL/6 strain used in these experiments, mall 
amounts of uncomplexed X glucuronidase have 
been detected in normal induced kidney (34). 
These observations suggest that in normal induced 
kidney the supply of egasyn available for complex- 
ing with glucuronidase becomes depleted. When 
Eg~ § heterozygotes, which contain about half 
2 A. J. Lusis and K. Paigen, 1976. Unpublished results. 
as much egasyn as normal mice (22), were in- 
duced for glucuronidase, they contained signifi- 
cantly less of the microsomal forms of glucuroni- 
dase than did induced Eg+/Eg + mice (Fig. 3). 
Also, the relative amounts of the microsomal 
forms of glucuronidase differed between the two 
types of mice; while normal homozygotes con- 
tained significant amounts of M2 and M3, the 
heterozygotes contained primarily M1 and the un- 
complexed glucuronidase tetramer X (Fig. 3). 
Thus, Eg~ + heterozygotes that contain half- 
normal levels of egasyn also have reduced levels of 
microsomal g ucuronidase when conditions are ar- 
ranged so that egasyn is no longer in excess. 
DISCUSSION 
Our experimental observations indicate that the 
availability of egasyn is a primary factor in deter- 
mining the partition of glucuronidase b tween ly- 
sosomes and endoplasmic reticulum. Levels of 
egasyn and microsomal glucuronidase are strongly 
correlated in different issues and during the de- 
velopment of a single tissue. Also, previous obser- 
vations how that phenobarbital is able to induce 
egasyn about two-fold, and that accompanying 
this induction isa significant shift in the subcellular 
distribution of glucuronidase from lysosomes to 
microsomes, although the total level of glucuroni- 
dase remains constant (25). 
There is one anomaly in the quantitative r la- 
tionship between egasyn levels and the membrane 
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FIGURE 3 Polyacrylamide gel electrophoresis of glucu- 
ronidase from kidneys of androgen-induced mice. Fe- 
male mice, about 60 days of age, were pelleted with 
testosterone asdescribed in Table II and were sacrificed 
about 10 days after pelleting. Kidneys were homoge- 
nized in 0.02 M imidazole, 0.25 M sucrose, pH 7.4, and 
these were extracted with 2% Triton X-100 and centri- 
fuged at 100,000 gfor 30 rain. Supernatant solutions (10 
/~l) were applied to polyacrylamide g ls, and electropho- 
resis was performed as described in Materials and Meth- 
ods. Gels were stained for glucuronidase activity and 
scanned at 550 nm. The separation ofthe X and L forms 
of glucuronidase was incomplete, and X is seen as a 
shoulder behind L. 
binding of glucuronidase. Halving the egasyn 
level, by making animals genetically heterozygous 
(Eg~ does not cause a significant shift in the 
subcellular localization of glucuronidase unless the 
animals are pushed to synthesize unusually large 
amounts of glucuronidase. However, doubling the 
egasyn level, via phenobarbital induction, is able 
to cause a significant shift in the subcellular locali- 
zation of glucuronidase ven when there is no 
change in enzyme activity (25). The explanation 
for this may be related to the fact that genetic 
manipulation to reduce egasyn levels has no effect 
on the synthesis of other membrane proteins, 
whereas phenobarbital causes a generalized prolif- 
eration of endoplasmic reticulum protein as well 
as an induction of egasyn. The additional mem- 
brane components induced by phenobarbital may 
influence the interaction between glucuronidase 
and egasyn. 
The syntheses of egasyn and glucuronidase ap- 
pear to be regulated independently. There is no 
correlation between the total levels of egasyn and 
glucuronidase among tissues, and glucuronidase 
but not egasyn is induced by androgen in kidney. 
This suggests that the major factor controlling the 
integration of glucuronidase into membranes, 
among cell types and during development, is the 
regulation of egasyn synthesis. In relation to this, a 
particularly interesting question that remains to be 
answered is whether egasyn is complexed with 
proteins other than glucuronidase. In both liver 
and kidney, only a small fraction of the total 
egasyn is complexed with glucuronidase. That the 
remainder may well be associated with other pro- 
teins is suggested by the observation that antigenic 
sites of egasyn are unmasked under conditions 
that would dissociate gasyn-protein complexes 
(21). Thus, egasyn synthesis may regulate the 
membrane binding of a family of proteins, only 
one of which is glucuronidase. 
Some evidence suggests that egasyn functions to 
stabilize the membrane binding of glucuronidase, 
once it has occurred, rather than to initiate the 
binding. First, under conditions of egasyn deple- 
tion, such as in androgen-induced ki neys of some 
mouse strains, small amounts of X glucuronidase, 
not complexed with egasyn, are present in mem- 
branes (34). Second, Ganschow and Smith 3, by 
following the incorporation of radioactively la- 
beled amino acids into microsomal and lysosomal 
glucuronidase, have obtained evidence that Eg o 
mice synthesize approximately normal amounts of 
membrane-bound X glucuronidase but that in the 
absence of egasyn the membrane-bound glucuron- 
idase is rapidly removed. 
The intracellular forms of glucuronidase have 
been examined in rabbit and rat tissues as well as 
in mice (2). Livers of both rabbit and rat have 
large amounts of glucuronidase activity in micro- 
somes as well as lysosomes, and the microsomal 
forms are extracted by Triton X-100 (3, 24). Bio- 
chemical studies uggest hat, as in mice, the en- 
zyme at both subcellular sites is derived from a 
common structural gene, although genetic evi- 
dence of this has not been obtained (2, 24). Mi- 
crosomal glucuronidase and lysosomal glucuroni- 
dase in rat liver differ in charge, but no evidence 
of macromolecular complexes has been presented 
3 R. Ganschow and K. Smith. Personal communication. 
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(24, 32). Rabbit liver, on the other hand, contains 
a series of glucuronidase molecular weight forms 
similar to those observed in mice; however, at- 
tempts to correlate these with different subcellular 
fractions have not yielded results which are as 
clear as those obtained with mouse tissues (3). 
There is now considerable vidence in support 
of the original concept hat the microsomal forms 
of glucuronidase xist complexed with egasyn in 
endoplasmic reticulum, and that these complexes 
are required for maintenance of glucuronidase in 
membranes. It is likely that this mechanism of 
membrane binding, involving noncovalent com- 
plexing with a specific integral membrane protein, 
is used widely among biological systems. Studies 
involving several "peripheral" membrane pro- 
teins, including mitochondrial ATPase (15, 23, 
29), cytochrome c (30, 31), and spectrin (33), 
have been reviewed by Singer (30). In common 
with glucuronidase, ach of these proteins appears 
to be anchored to membrane by specific noncova- 
lent interaction with integral membrane proteins. 
Membrane binding by this mechanism may have 
special biological utility. Structurally, it provides a 
means of stabilizing the attachment of highly polar 
molecules, such as glucuronidase (37), to mem- 
branes, and it allows considerable xposure of the 
bound protein to the cytosol, which may be impor- 
tant for the functioning of certain enzymes. In 
terms of regulation, it allows independent control 
of the total activity and intracellular distribution of 
an enzyme, and provides a mechanism for coordi- 
nating the membrane binding of a set of enzymes. 
The studies with egasyn now provide evidence that 
integral anchor proteins uch as egasyn may have a 
~egulatory as well as a structural function. 
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